22, January 2024
Biya regime launches world’s first nationwide malaria vaccination programme 0
The world’s first routine vaccine programme against malaria has started in Cameroon, in a move projected to save thousands of children’s lives across Africa.
The symbolic first jab was given to a baby girl named Daniella at a health facility near Yaoundé on Monday.
Every year 600,000 people die of malaria in Africa, according to the World Health Organization (WHO).
Children under five make up at least 80% of those deaths.
Cameroon is offering the RTS,S vaccine free of charge to all infants up to the age of six months old.
Patients require a total of four doses. Health officials say these will be given at the same time as other routine childhood vaccines to make it easier for parents.
It comes after successful pilot campaigns in Kenya, Ghana and Malawi – where the vaccine caused a 13% drop in malaria deaths in children of eligible age, says Unicef.
The jab is known to be effective in at least 36% of cases, according to US researchers, meaning it could save over one in three lives.
While the rollout is undoubtedly a relief and a life-saver, its relatively low efficacy rate means that it is not a “silver bullet”, argues Willis Akhwale at End Malaria Council Kenya.
But for medics it is an important additional tool in the fight against malaria alongside mosquito nets and malaria tablets. Using all three together potentially gives children 90% protection from malaria, one UK-led study estimates.
“We have a capacity to considerably reduce the number of cases and deaths from malaria and accelerate the elimination of the disease,” Cameroonian doctor Shalom Ndoula, who helped to lead the vaccine rollout in his country, told BBC Newsday.
Development of the RTS,S vaccine has taken 30 years of research by the British drug-maker GSK.
The World Health Organization, which approved the vaccine, hailed the launch in Cameroon as a historic moment in the global fight against the mosquito-borne disease.
There was another breakthrough earlier this month, when Cape Verde became the first sub-Saharan African country in 50 years to be officially declared malaria-free by the global health body.
‘Safe, effective and free’
Fears and doubts among some Cameroonians about the safety and efficacy of the doses have raised concerns about vaccine hesitancy.
“When people say we are being used as guinea pigs, that’s not particularly true,” Wilfred Fon Mbacham, who is a Cameroonian king and also a professor of public health biotechnology specialising in malaria, told BBC Newsday.
“We as scientists have to do much more to educate the public on what it is, and the benefits it has, so that we can calm their fears.”
Vaccination official Daniele Ekoto at Monday’s launch told the BBC she was reassuring mothers after administering doses to their children, insisting that “it’s a vaccine that’s safe, effective and free”.
But for others the benefits are obvious.
“I decided to vaccinate my child to avoid malaria. It’s a bad thing and when it affects a child, they can easily die,” one mother told the BBC at the same vaccination centre in Soa, near Yaoundé, where Monday’s launch happened.
In 2021, Africa accounted for 95% of malaria cases globally and about 96% of related deaths.
“I have prayed and waited all my life for this vaccine”, Mr Mbacham told the BBC.
The WHO says Cameroon records about six million malaria cases every year, with 4,000 deaths in health facilities – most of them children below five.
Six-month-old children in 42 districts with the greatest rates of morbidity and mortality will receive four doses until the age of two.
Twenty other countries aim to roll out the programme this year, according to the global vaccine alliance, Gavi. Among them are Burkina Faso, Liberia, Niger and Sierra Leone.
There is already a big demand for doses, but only about 18 million are available for allocation before 2025, according to Gavi.
It falls short of what is needed by the countries the vaccine alliance has recommended for approval.
The anticipated rollout of a second jab – R21 – developed by Oxford University, is expected to significantly increase the number of doses available for use.
This is to be manufactured by the Serum Institute of India, which aims to make 100 million doses per year, so long as it successfully passes the regulatory approvals following its recommendation for use by the WHO last year.
Source: BBC
22, January 2024
Liberia’s new president Boakai sworn in with pledge to ‘rescue’ Africa’s oldest republic 0
Liberia’s new president, Joseph Boakai, was sworn into office Monday after his narrow win in a November election. Boakai, who at age 79 is the country’s oldest sitting head of state, promised to unite and rescue Africa’s oldest republic from its economic woes.
“Partisanship must give way to nationalism,” Boakai told citizens and foreign delegation members who attended his inauguration ceremony in Monrovia, Liberia’s capital. He listed improving adherence to the rule of law, fighting corruption and renewing “the lost hope” of citizens as his priorities.
The ceremony, however, ended abruptly after Boakai, who wore traditional Liberian attire for the occasion, began to show signs of physical distress while speaking. Officials led him away from the podium after he unsuccessfully tried to continue his address.
A spokesperson for Boakai’s political party said the president’s weakness was caused by heat and had nothing to do with his health.
Boakai has dismissed concerns about his age, arguing that it came with a wealth of experience and achievements that would benefit the country.
He won a tight run-off election to defeat Liberia’s youngest-ever president, George Weah. Public goodwill toward soccer legend-turned-politician Weah waned as he neared the end of his first six-year term. Critics accused him of not fulfilling campaign promises to fix Liberia’s ailing economy, stamp out corruption and to ensure justice for victims of the country’s back-to-back civil wars between 1989 and 2003.
Boakai, who earned a university degree in business administration, has been active in Liberia’s national politics since the 1980s, when he served as the agriculture minister. Starting in 2006, he spent 12 years as vice president under Africa’s first democratically elected female leader, Ellen Johnson Sirleaf.
He lost his first run for the presidency in 2017 to Weah, who took over from Sirleaf in the West African nation’s first democratic transfer of power since the end of its civil wars. Boakai touted his second presidential campaign as a rescue mission to free Liberians from what he described as Weah’s failed leadership.
His promises notwithstanding, any positive changes from the new Liberian leader are likely to come slowly considering how different Boakai’s agenda is from his predecessors, according to Ibrahim Nyei, a researcher and political analyst at Liberia’s Ducor Institute for Social and Economic Research.
“It is not going to be a walk in the park for the Boakai administration,” Nyei said. “The new leadership will have to review concessions agreements signed by Weah and Ellen’s governments to establish which one works in the interest of Liberia (and) seek new international partners that will help address some of the country’s challenges.”
Monrovia resident Ansu Banban Jr. said he thinks Boakai will improve the lives of citizens. “I do not expect anything less than good from the president,” Banban said.
Boakai has a public reputation as a “hardworking and humble politician” whose personality and political experience suggest he “may show more dedication toward combating corruption than previous administrations,” said Zoe McCathie, a political and security analyst at Africa-focused Signal Risk Consulting.
“Nevertheless, it is unlikely that Boakai will be able to fully address this matter due to the entrenched nature of corruption within Liberian politics,” McCathie said. “Achieving sustained economic growth is expected to be an uphill battle for the Boakai administration (because) of the Liberian economy’s lack of diversification and dependence on imports.”
Source: AP